Irem Ozkan‐Dagliyan

Statistics

Publications

Citations

979

H-Index

Active since

2013

Affiliations

University of North Carolina at Chapel Hill(Current)

Berlin Institute of Health at Charité - Universitätsmedizin Berlin

Heidelberg University

George Mason University

Translational Genomics Research Institute

Irem Ozkan‐Dagliyan is an author at University of North Carolina at Chapel Hill specializing in life sciences, signal transduction, and cell signaling.

ORCID

Publications per year

2013–2024

Publications

Dual modes of CLOCK:BMAL1 inhibition mediated by Cryptochrome and Period proteins in the mammalian circadian clock

Rui Ye, Cristopher P. Selby, Yi‐Ying Chiou et al. · Genes & Development · 2014 · 240 citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +17

KRAS Suppression-Induced Degradation of MYC Is Antagonized by a MEK5-ERK5 Compensatory Mechanism

Angelina V. Vaseva, Devon R. Blake, Thomas S.K. Gilbert et al. · Cancer Cell · 2018 · 192 citations · Full text

Life Sciences, Genetics, Molecular Biology +14

Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i> Mutant Pancreatic Cancer

Craig M. Goodwin, Andrew M. Waters, Jennifer E. Klomp et al. · Cancer Research · 2022 · 160 citations · Full text

Medicine, Oncology, Pharmacology +17

Computational design of chemogenetic and optogenetic split proteins

Onur Dağliyan, A. Krokhotin, Irem Ozkan‐Dagliyan et al. · Nature Communications · 2018 · 107 citations · Full text

Life Sciences, Biochemistry, Bioinformatics +17

Low-Dose Vertical Inhibition of the RAF-MEK-ERK Cascade Causes Apoptotic Death of KRAS Mutant Cancers

Irem Ozkan‐Dagliyan, J. Nathaniel Diehl, Samuel D. George et al. · Cell Reports · 2020 · 107 citations · Full text

Life Sciences, Cancer Biology, Oncology +17

1–5 of 11